Sol-Gel Technologies Assets & Liabilities Overview 2016-2023 | SLGL
Sol-Gel Technologies assets & liabilities overview from 2016 to 2023. Assets & liabilities overview can be defined as overview of the balance sheet showing the primary categories of assets, liabilities and equity in a single chart.
Sol-Gel Technologies Annual Assets & Liabilities Overview
(Millions of US $) |
Sol-Gel Technologies Quarterly Assets & Liabilities Overview
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.026B |
$0.002B |
|
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
|
